Old medications and new targeted therapies in systemic sclerosis

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Systemic sclerosis (SSc) is a severe autoimmune condition characterized by multi-organ involvement.
• SSc significantly impairs patients' quality of life and is associated with high morbidity.
• Current treatments are often organ-specific and palliative, not curative.

Purpose of the Study:

• To review established and novel therapeutic strategies for managing systemic sclerosis (SSc).
• To provide an overview of treatments applicable in clinical practice for SSc patients.

Main Methods:

• Literature review of existing and emerging therapies for systemic sclerosis.
• Synthesis of information on management approaches for SSc in clinical settings.

Main Results:

• SSc management requires an organ-based approach.
• Newer therapies offer potential for disease modification in certain SSc aspects.
• A combination of traditional and novel treatments is crucial for SSc care.

Conclusions:

• Effective management of systemic sclerosis involves a comprehensive strategy.
• Ongoing research into disease-modifying therapies is vital for improving SSc outcomes.
• This review consolidates current knowledge on SSc treatments for clinical application.